Thymic carcinoma in children: A report from the polish pediatric rare tumors study

Pediatric Blood and Cancer

Volumn 54, Issue 7, 2010, Pages 916-920

  Stachowicz Stencel, Teresa ^a   Bien, Ewa ^a   Balcerska, Anna ^a   Godzinski, Jan ^b   Synakiewicz, Anna ^a   Madziara, Wojciech ^c   Perek Polnik, Marta ^d   Peregud Pogorzelski, Jarosaw ^e   Pietras, Wojciech ^f   Pobudejska, Aneta ^g   Kurylak, Andrzej ^h   Mankowski, Przemyslaw ⁱ  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b T Marciniak Lower Silesia Specialist Hospital Wroclaw   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

^f WROCLAW MEDICAL UNIVERSITY   (Poland)

^g Medical University   (Poland)

^h NICOLAUS COPERNICUS UNIVERSITY   (Poland)

ⁱ POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Children; Prognosis; Stage; Thymic carcinoma; Treatment

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ARTICLE; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; MALE; MEDIASTINUM TUMOR; PARANEOPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CARCINOMA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NEOPLASM STAGING; POLAND; RADIOTHERAPY; RETROSPECTIVE STUDIES; THYMECTOMY; THYMUS NEOPLASMS;

EID: 77951725278     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22482     Document Type: Article

References (38)

1. Strollo DC, Rosado-de-Chrestenson ML. Tumors of the thymus. J Thorac 1999;14:152-171.
2. Chahinian AP. Thymomas. In: Holland JF, et al. editor. Cancer medicine. Philadelphia: Lea and Febiger; 1993. pp. 1355-1361.
3. Rosai J. Histological typing of tumors of the thymus, 2nd edition. New York: Springer; 1999. pp. 13-15.
4. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behaviour of thymoma: A clinical study of 273 patients. Cancer 2002;94:623-632. (Pubitemid 34132289)
5. Suster S, Moran CA. Thymic carcinoma: Spectrum of differentiation and histologic types. Pathology 1998;30:111-122. (Pubitemid 28211781)
6. Ogawa K, Tolta T, Uno T, et al. Treatment and prognosis of thymic carcinoma: A retrospective analysis of 40 cases. Cancer 2002;94:3115-3119. (Pubitemid 34670493)
7. Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-429. (Pubitemid 34787609)
8. Sperling B, Marschall J, Kennedy R, et al. Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg 2003;46:37-42. (Pubitemid 36245401)
9. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492. (Pubitemid 12228012)
10. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy of invasive thymoma. J Clin Oncol 1990;8:1419-1423.
11. Greene MA, Malias MA. Agressive multimodality treatment of invasive thymic carcinoma. J Thorac Cardiovasc Surg 2003;125:434-436. (Pubitemid 36228333)
12. Kondo K, Yasumasa M. Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Am Thorac Surg 2003;76:878-885. (Pubitemid 37100765)
13. Schmidt-Wolf IG, Rockstroh JK, Schuller H, et al. Malignant thymoma: Current status of classification and multimodality treatment. Ann Hematol 2003;82:69-76. (Pubitemid 36700977)
14. Ayadi-Kaddour A, Bacha D, Smati B, et al. Primary thymic carcinoma. Three cases and a reviewof the literature. Rev Pneumol Clin 2009;65:113-117.
15. Yaris N, Nas Y, Cobanoglu U, et al. Thymic carcinoma in children. Pediatr Blood Cancer 2006;47:224-227.
16. Levy Y, Afek A, Sherer Y, et al. Malignant thymoma associated with autoimmune diseases: A retrospective study and review of the literature. Semin Arthritis Rheum 1998;28:73-79. (Pubitemid 28480891)
17. Emir S, Kutluk T, Topaloǧlu R, et al. Sclerodermia in a child after chemotherapy for cancer. Clin Exp Rheumatol 2001;19:221-223.
18. Cameron RB, Loehrer PJ, Sr., Thomas CR, Jr., Neoplasms of the mediastinum. In: De Vita VT, Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and practise of oncology, 7th edition. Philadelphia: LippincottWilliams &Wilkins; 2005. pp. 845-858.
19. Rios A, Torres J, Galindo PJ, et al. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg 2002;21:307-313. (Pubitemid 34134488)
20. Chung DA. Thymic carcinoma: Analysis of nineteen clinicopathological studies. Thorac Cardiov Surg 2000;48:114-119.
21. Igawa S, Murakami H, Takahashi T, et al. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer 2010;67:194-197.
22. Yano M, Sasaki H, Yokoyama T, et al. Thymic carcinoma with dissemination: Aretrospective analysis of ten patients. Gen Thorac Cardiovasc Surg 2008;56:335-339. (Pubitemid 351952059)
23. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76:1866-1872. (Pubitemid 37510495)
24. Rajan A, Giaccone G. Treatment of advanced thymoma and thymic carcinoma. Curr Treat Options Oncol 2008;9:277-287.
25. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report. Lung Cancer 2004;44:369-379. (Pubitemid 38609446)
26. Dhall G, Ginsburg HB, Bodenstein L, et al. Thymoma in children. J Peditr Hematol Oncol 2004;26:681-685.
27. Eng TY, Thomas CR, Jr. Radiation therapy in the management of thymic tuomrs. Thorac Cardiovasc Surg 2005;17:32-40.
28. Nonaka T, Tamami Y, Higuchi K, et al. The role of radiotherapy for thymic carcinoma. Jpn J Clin Oncol 2004;34:722-726.
29. Wright CD, Choi NC,Wain JC, et al. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 2008;85:385-389.
30. Yano M, Sasaki H, Yokomyama T, et al. Thymic carcinoma: 30 Cases at a single institution. J Thorac Oncol 2008;3:265-269. (Pubitemid 351654326)
31. Komatsu Y, Koizumi T, Tanabe T, et al. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma - Three cases. Anticancer Res 2006;26:4851-4855. (Pubitemid 46032123)
32. Yokoi K, Matsuguma H, Nakahara R, et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2007;2:73-78. (Pubitemid 47163933)
33. Greene MA, Malias MA. Agressive multimodality treatment of invasive thymic carcinoma. J Thoras Cardiovasc Surg 2003;125:434-436. (Pubitemid 36228333)
34. Maruyama R, Suemitsu R, Okamoto T, et al. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients. Oncology 2006;70:325-329.
35. Venuta F, Rendina EA, Coloni GF. Multimodality treatment of thymic tumors. Thorac Surg Clin 2009;10:71-81.
36. Bernatz PE, Harrison EG, Clagett OT. Thymoma: A clinicopathologic study. J Thorac Cardiovasc Surg 1961;42:424-444.
37. Rosai J, Levine G. Tumors of the thymus.Washington, DC: Armed Forces Institute of Pathology; 1976. pp. 34-104. Atlas of Tumor Pathology, Second Series, Fascicle 13.
38. Muller-Hermelink HK, Marino M, Palestro G, et al. Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985;408:143-161. (Pubitemid 16174495)